Shares of San Diego-based Atyr Pharma Inc. (NASDAQ:LIFE) rose 6.3% to $5.45 on the company's first full day of trading following a 1-for-14 reverse split of its common stock that helped the company regain compliance with the Nasdaq minimum bid price requirement.

Carrick Therapeutics Ltd., of Dublin, said it plans to establish business operations in Boston, and made public the transition of CEO leadership from Elaine Sullivan, based in Dublin, to Tim Pearson, based in Boston.